Cannaisseur Group Inc. (TCRG): Revenue
$0
Year ended 2025-12-31
$0
Trailing 12 months to 2026-06-30
| Period ended | Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $0 | -100.0% | 2026-03-23, From 2025-01-01 |
| 2024-12-31 | $700 | -98.7% | 2026-03-23, From 2024-01-01 |
| 2023-12-31 | $53.1K | -39.7% | 2025-03-21, From 2023-01-01 |
| 2022-12-31 | $88.1K | n/a | 2024-04-15, From 2022-01-01 |
Revenue at similar companies
| Company | Year ended | Revenue | Change YoY |
|---|---|---|---|
| Cannaisseur Group Inc. (TCRG) | 2025-12-31 | $0 | -100.0% |
| Cyanotech Corp (CYAN) | 2025-03-31 | $24.21M | +5.0% |
| Natural Alternatives International Inc (NAII) | 2026-06-30 | $142.51M | +9.7% |
| C21 Investments Inc. (CWLXF) | 2026-03-31 | $32.61M | +8.3% |
| USANA Health Sciences Inc (USNA) | 2026-01-03 | $925.26M | +8.3% |
| Mannatech Inc (MTEX) | 2025-12-31 | $108.04M | -8.3% |
| Nutra Pharma Corp (NPHC) | 2025-12-31 | $257.6K | +4.6% |
| Charlie's Holdings, Inc. (CHUC) | 2025-12-31 | $20.92M | +169.4% |
| Adia Med, Inc. (ADIA) | 2025-12-31 | $700.5K | n/m |
Compare TCRG, CYAN, NAII, CWLXF side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗